Feedback (LON:FDBK) Stock Passes Above 50 Day Moving Average – What’s Next?

Feedback plc (LON:FDBK)’s stock price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 8.45 and traded as high as GBX 9.75. Feedback shares last traded at GBX 9.75, with a volume of 87,764 shares changing hands.

Feedback Stock Up 14.0%

The stock has a market cap of £4.81 million, a P/E ratio of -0.43 and a beta of 0.77. The business has a 50-day simple moving average of GBX 8.45 and a 200-day simple moving average of GBX 11.33.

Insider Activity

In other news, insider Emma Oswick (Stuart) bought 60,459 shares of the stock in a transaction dated Tuesday, December 23rd. The stock was bought at an average cost of GBX 8 per share, with a total value of £4,836.72. Also, insider Tom Oakley acquired 60,904 shares of the business’s stock in a transaction that occurred on Tuesday, December 23rd. The stock was acquired at an average price of GBX 8 per share, for a total transaction of £4,872.32. 7.98% of the stock is owned by corporate insiders.

Feedback Company Profile

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.